Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

Room In The Lobby For Multiple Supplement Industry Trade Groups – Expert

This article was originally published in The Tan Sheet

  • News

Executive Summary

Consolidating the dietary supplement industry’s lobbying presence in Washington is easier said than done and ultimately may be unnecessary.

You may also be interested in...



Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife

The dietary supplement industry lost one of its most active and vocal scientific leaders in Washington when Andrew Shao departed the Council for Responsible Nutrition for an executive post with Herbalife.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Table

View full table

Topics

Tags:
OTC Drugs
UsernamePublicRestriction

Register

PS105348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By